| Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo PS Shirude, R Shandil, C Sadler, M Naik, V Hosagrahara, S Hameed, ... Journal of Medicinal Chemistry 56 (23), 9701-9708, 2013 | 164 | 2013 |
| Ring-substituted imidazoles as a new class of anti-tuberculosis agents P Gupta, S Hameed, R Jain European Journal of Medicinal Chemistry 39 (9), 805-814, 2004 | 156 | 2004 |
| Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis SJ Tantry, SD Markad, V Shinde, J Bhat, G Balakrishnan, AK Gupta, ... Journal of medicinal chemistry 60 (4), 1379-1399, 2017 | 118 | 2017 |
| Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis PS Shirude, P Madhavapeddi, M Naik, K Murugan, V Shinde, ... Journal of Medicinal Chemistry 56 (21), 8533-8542, 2013 | 109 | 2013 |
| Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate S Hameed P, S Solapure, V Patil, PP Henrich, PA Magistrado, S Bharath, ... Nature Communications 6 (1), 6715, 2015 | 72 | 2015 |
| Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA gyrase B MG Kale, A Raichurkar, SH P, D Waterson, D McKinney, MR Manjunatha, ... Journal of medicinal chemistry 56 (21), 8834-8848, 2013 | 67 | 2013 |
| A rapid and direct access to symmetrical/unsymmetrical 3, 4-diarylmaleimides and pyrrolin-2-ones M Pal, NK Swamy, PS Hameed, S Padakanti, KR Yeleswarapu Tetrahedron 60 (18), 3987-3997, 2004 | 53 | 2004 |
| Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing S Hameed P, A Raichurkar, P Madhavapeddi, S Menasinakai, S Sharma, ... ACS Medicinal Chemistry Letters 5 (7), 820-825, 2014 | 51 | 2014 |
| Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosis S Hameed P, V Patil, S Solapure, U Sharma, P Madhavapeddi, ... Journal of Medicinal Chemistry 57 (11), 4889-4905, 2014 | 44 | 2014 |
| N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds S Ramachandran, S Hameed P, A Srivastava, G Shanbhag, S Morayya, ... Journal of Medicinal Chemistry 57 (15), 6642-6652, 2014 | 43 | 2014 |
| Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy RR Kale, MG Kale, D Waterson, A Raichurkar, SP Hameed, ... Bioorganic & Medicinal Chemistry Letters 24 (3), 870-879, 2014 | 43 | 2014 |
| Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis S Solapure, K Mukherjee, V Nandi, D Waterson, R Shandil, M Balganesh, ... Antimicrobial agents and chemotherapy 58 (1), 61, 2014 | 41 | 2014 |
| Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase V Patil, M Kale, A Raichurkar, B Bhaskar, D Prahlad, M Balganesh, ... Bioorganic & Medicinal Chemistry Letters 24 (9), 2222-2225, 2014 | 37 | 2014 |
| Aminoazabenzimidazoles, a novel class of orally active antimalarial agents S Hameed P, M Chinnapattu, G Shanbag, P Manjrekar, K Koushik, ... Journal of Medicinal Chemistry 57 (13), 5702-5713, 2014 | 33 | 2014 |
| Pyrazolopyrimidines Establish MurC as a Vulnerable Target in Pseudomonas aeruginosa and Escherichia coli S Hameed P, P Manjrekar, M Chinnapattu, V Humnabadkar, G Shanbhag, ... ACS Chemical Biology 9 (10), 2274-2282, 2014 | 22 | 2014 |
| Nonfluoroquinolone-based inhibitors of mycobacterial type II topoisomerase as potential therapeutic agents for TB PS Shirude, S Hameed Annual reports in medicinal chemistry 47, 319-330, 2012 | 22 | 2012 |
| Nitrothiophene carboxamides, a novel narrow spectrum antibacterial series: mechanism of action and efficacy S Hameed P, N Bharatham, N Katagihallimath, S Sharma, R Nandishaiah, ... Scientific Reports 8 (1), 7263, 2018 | 17 | 2018 |
| Identification and mitigation of a reactive metabolite liability associated with aminoimidazoles A Srivastava, S Ramachandran, SP Hameed, VK Ahuja, VP Hosagrahara Chemical Research in Toxicology 27 (9), 1586-1597, 2014 | 17 | 2014 |
| Left-hand side exploration of novel bacterial topoisomerase inhibitors to improve selectivity against hERG binding S Hameed P, P Manjrekar, A Raichurkar, V Shinde, J Puttur, G Shanbhag, ... ACS medicinal chemistry letters 6 (7), 741-746, 2015 | 16 | 2015 |
| UDP-N-Acetylmuramic Acid l-Alanine Ligase (MurC) Inhibition in a tolC Mutant Escherichia coli Strain Leads to Cell Death V Humnabadkar, KR Prabhakar, A Narayan, S Sharma, S Guptha, ... Antimicrobial Agents and Chemotherapy 58 (10), 6165-6171, 2014 | 12 | 2014 |
